Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor beta variable 7-6 (TRBV7-6) is a protein segment comprising the variable region of the beta chain of the T cell receptor (TCR), part of the immunoglobulin superfamily, expressed on the surface of T lymphocytes as a heterodimer with a TCR alpha chain[1][5]. The TCR beta variable region confers antigen specificity by binding peptide-major histocompatibility (MHC) complexes on antigen-presenting cells, initiating signaling cascades through CD3 and associated proteins to activate T cells and mediate adaptive immune responses[1][2][5]. TRBV7-6 is specifically generated by somatic V-(D)-J recombination during T cell development and contributes to the diversity and specificity of the T cell repertoire. While not directly addressed by current drugs, TCR beta variable regions, including TRBV7-6, are key components in the monitoring of immune responses and may serve as biomarkers or targets in immunotherapeutic applications, though their highly diverse nature limits direct drug targeting at present[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor beta variable 7-6 (TRBV7-6).